Difficulty: Medium
Average Score: 81%
Practice
A 44-year-old woman with Crohn├óÔé¼Ôäós disease in the ileum and right colon is currently maintained on medical therapy including sulfasalazine. Symptoms are currently at baseline with minimal abdominal pain and diarrhea. The most likely reason for improved pain may relate to which of the following compounds/substances?
Correct answer
D
Rationale
The correct answer is D) 5-Aminosalicylate. In this case, the patient is on sulfasalazine, which is a prodrug consisting of sulfapyridine and 5-aminosalicylate. The active form responsible for the anti-inflammatory effects in conditions like Crohn's disease is 5-aminosalicylate.
Option A) Phenazopyridine is a urinary analgesic and would not be relevant in this scenario.
Option B) Sulfamethoxazole is an antibiotic and not typically used for managing Crohn's disease symptoms.
Option C) Sulfapyridine is a component of sulfasalazine but is not responsible for the anti-inflammatory effects seen in this context.
Educationally, understanding the mechanism of action of medications is crucial in optimizing patient care. Knowing that 5-aminosalicylate is the active component of sulfasalazine helps in comprehending its role in managing inflammatory bowel diseases like Crohn's. This knowledge aids healthcare providers in making informed decisions regarding treatment plans for their patients.
Option A) Phenazopyridine is a urinary analgesic and would not be relevant in this scenario.
Option B) Sulfamethoxazole is an antibiotic and not typically used for managing Crohn's disease symptoms.
Option C) Sulfapyridine is a component of sulfasalazine but is not responsible for the anti-inflammatory effects seen in this context.
Educationally, understanding the mechanism of action of medications is crucial in optimizing patient care. Knowing that 5-aminosalicylate is the active component of sulfasalazine helps in comprehending its role in managing inflammatory bowel diseases like Crohn's. This knowledge aids healthcare providers in making informed decisions regarding treatment plans for their patients.